| Eugene C Fletcher, MD | |
|
1600 Goshen Ln, Goshen, KY 40026-9509 | |
| (502) 228-2636 | |
| Not Available |
| Full Name | Eugene C Fletcher |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1600 Goshen Ln, Goshen, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770574790 | NPI | - | NPPES |
| 000000645210 | Other | IN | ANTHEM BCBS |
| 2444577000 | Other | KY | PASSPOSRT ADVANTAGE |
| 64296866 | Medicaid | KY | |
| 000000311476 | Other | KY | ANTHEM |
| 50003129 | Other | KY | PASSPORT |
| 200057650B | Medicaid | IN |
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
USA Today reports that "doctors have long been rewarded for providing more care, though more isn't always better. Three recent studies show that a doctor's instincts are no match for hard science." The studies include one of 800 high blood pressure patients that found opening clogged arteries with stents didn't lower blood pressure and actually raised side effects.
Sepracor Inc. announced today the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. In this study, OMNARIS HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction versus placebo in the reflective total nasal symptom score averaged over a two-week treatment period.
Meditation has analgesic benefits associated with creating a relaxed state of mind and enhancing the ability to moderate reactions to pain, according to new research published in The Journal of Pain, the peer review publication of the American Pain Society.
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, much like a trash bag.
› Verified 6 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
USA Today reports that "doctors have long been rewarded for providing more care, though more isn't always better. Three recent studies show that a doctor's instincts are no match for hard science." The studies include one of 800 high blood pressure patients that found opening clogged arteries with stents didn't lower blood pressure and actually raised side effects.
Sepracor Inc. announced today the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. In this study, OMNARIS HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction versus placebo in the reflective total nasal symptom score averaged over a two-week treatment period.
Meditation has analgesic benefits associated with creating a relaxed state of mind and enhancing the ability to moderate reactions to pain, according to new research published in The Journal of Pain, the peer review publication of the American Pain Society.
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, much like a trash bag.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eugene C Fletcher, MD 1600 Goshen Ln, Goshen, KY 40026-9509 Ph: (520) 228-2636 | Eugene C Fletcher, MD 1600 Goshen Ln, Goshen, KY 40026-9509 Ph: (502) 228-2636 |
News Archive
USA Today reports that "doctors have long been rewarded for providing more care, though more isn't always better. Three recent studies show that a doctor's instincts are no match for hard science." The studies include one of 800 high blood pressure patients that found opening clogged arteries with stents didn't lower blood pressure and actually raised side effects.
Sepracor Inc. announced today the preliminary results of a large-scale, 671-patient Phase III study of OMNARIS® (ciclesonide) HFA, an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. In this study, OMNARIS HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction versus placebo in the reflective total nasal symptom score averaged over a two-week treatment period.
Meditation has analgesic benefits associated with creating a relaxed state of mind and enhancing the ability to moderate reactions to pain, according to new research published in The Journal of Pain, the peer review publication of the American Pain Society.
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, much like a trash bag.
› Verified 6 days ago